Schedule 13G ownership disclosure

Relmada Therapeutics Inc

Security class unavailable · CUSIP: 75955J402

Event date: 2019-10-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-19-006748
Form type
SC 13G
Filer
RELMADA THERAPEUTICS, INC.
CIK
CIK 1553643
Filed
Oct 31, 2019
Reporting period
Oct 21, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub